HAIR

We offer a variety of hair options for women and men ranging from basic cut and style to highlights, gloss, treatments and more.

Learn More

NAILS

From pedicure and manicures to acrylic nails and toes we have just the right option to help you look your best.

Learn More

SPA

Everyone deserves to be pampered. We can  help you relax and rejuvenate w/ a facial, massage or with one of our spa packages.

Learn More

Caring for chronic diseases in a fragmented health care system Ed Wagner.

Caring for chronic diseases in a fragmented health care system Ed Wagner, MD, MPH, knew there had to be a better way. He and Group Health colleagues lay out 15 years back to explore how better to engage patients with chronic diseases in effective care and attention. With Robert Hardwood Johnson Foundation support, the Chronic was developed by them Care Model. More than 1,500 U.S. And international medical practices have adopted the Model. Now the biggest roundup of proof on how the Model performs in practice confirms that it works. This review is normally in the January/February 2009 problem of Health Affairs, centered on an integral part of reforming health care: caring for chronic illnesses in a fragmented healthcare system.If it weren’t for these cannabinoids in breasts milk, newborn children wouldn’t normally understand how to eat, nor would they possess the desire to consume necessarily, which could bring about severe malnourishment and death even. Contrary to popular belief, the process is similar to how adult individuals who smoke pot get the munchies, as newborn kids who are breastfed normally receive dosages of cannabinoids that result in hunger and promote growth and development. [E]ndocannabinoids have already been detected in maternal milk and activation of CB1 receptors appears to be critical for milk sucking. Apparently activating oral-motor musculature, says the abstract of a 2004 study on the endocannabinoid receptor system that was released in the European Journal of Pharmacology. The medical implications of these novel developments are significant and suggest a promising potential for cannabinoids in pediatric medication for conditions including ‘non-organic failure-to-thrive’ and cystic fibrosis.